President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay.

As in negotiations with foreign nations, minor concessions by drug companies are more likely than a true overhaul.

President Trump will hold a press conference Monday morning with Health and Human Services Secretary Robert F. Kennedy Jr. to announce an executive order to cap prescription drug and pharmaceutical prices at the lowest cost offered in any other country.

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.